Summary.-The formation of lung colonies by i.v. injected Lewis lung-tumour cells in syngeneic recipients was greatly enhanced by prior treatment of the mice with cyclophosphamide. The lung-cloning efficiency was linearly related to cyclophosphamide dose and the optimum time of treatment was 2-4 days before the injection of tumour cells. The resulting lung colonies had a similar size distribution to colonies in untreated recipients. Bleomycin, local thoracic irradiation and wholebody irradiation were much less effective in enhancing the lung-cloning efficiency.
THE production of artificial lung metastases by i.v. injected cells has been used as a method of assaying the clonogenic capacity of cells removed from treated murine tumours. This approach was first described by Hill and Bush (1969) using the KHT sarcoma, and since that time it has been applied to a number of other mouse tumouirs including the C22LR osteosarcoma (van Putten et al., 1975) and the Lewis lung tumour and B 16 melanoma (Hill and Stanley, 1975) . A high cloning efficiency in the lungs for i.v. injected cells is important in reducing the possibility that the colonies are formed by a selected group of tumour cells and also because the higher the cloning efficiency the greater the sensitivity of the assay. Brown (1973) showed that local thoracic irradiation increased the lung-cloning efficiency of the KHT sarcoma, and more recently van Putten et al. (1975) have shown that a variety of systemically administered cytotoxic agents enhance the lung-cloning efficiency of the C22LR osteosarcoma.
The present work was designed to confirm that drug-induced enhancement of lung cloning also occurs with the Lewis lung tumour, and to investigate in 44 particular the considerable enhancement that is found using cyclophosphamide. MATERIALS Hill and Bush (1969) and Hill and Stanley (1975) 
RESULTS
Three cytotoxic agents were investigated for their ability to enhance lung colony formation by the Lewis lung tumour: cyclophosphamide (CY) (the agent that in the hands of van Putten et al. (1975) gave the greatest enhancement with the C22LR osteosarcoma) local thoracic or whole-body irradiation (found by Brown (1973) to enhance colony formation by the KHT sarcoma) and bleomycin (because of its tendency to enhance radiation-induced lung damage). The experiments were designed to measure the "enhancement factor" due to pretreatment of the recipient mice (i.e. the ratio of lung-colony counts in treated and control mice given the same cell suspension). All mice received 106 HR cells and 106 microspheres mixed with the required dose of viable tumour cells, and each experiment included untreated controls. Treatment with CY was found greatly to enhance the lung-cloning efficiency ( Fig. 1) . Using a dose of 250 mg/kg, given i.p. at up to 9 days before the cells, the enhancement factor was always greater than 5, and it showed a broad peak in the region of 2-4 days before cell injection. The precise shape of this peak is difficult to define because of inter-experiment variations in lung-colony enhancement. In our experience, lung-cloning efficiency has sometimes varied by a factor of 195-2 0 between separate groups of mice in one experiment, and by more than this between experiments (Hill and Stanley, 1975) . In spite of this variation, the data shown in Fig. 1 indicate that within the optimum range of intervals (2-4 days) the lung-colony enhancement factor was in the range 20-35. Even when CY was given only 6 h before the cells, a considerable level of enhancement (10-15) was still observed. Porter and Berry (1963) . The horizontal bars show the 95% confidence limits on the TD50-implants of known cell numbers to reach a standard leg diameter of 10 mm showed that pretreatment had no effect on the early growth rate of tumour implants. All the data in Fig. 4 are consistent with a cumulative Poisson relation between take probability and the inoculum size, indicating that the improvement was not due to pretreatment making the receptivity of the implantation sites more uniform. It appears t;o be due to a decrease in the number of implanted cells that was required for the initiation of tumouir growth.
DISCUSSION
Drug-induced enhancement of lung cloning is interesting from at least 3 points of view: as a means of improving the sensitivity of the lung-colony assay for clonogenic cell survival; as a potential risk in adjuvant chemotherapy; and, from a fundamental standpoint, as a mechanism in metastasis that needs to be understood.
Our interest in this phenomenon stemmed primarily from the first point of view. The lung-colony assay has proved to be a valuable technique for the measurement of clonogenic cell survival in the Lewis lung tumour (Hill and Stanley, 1975; Shipley et al., 1975; Steel and Adams, 1975 van Putten et al. (1975) in identifying the strong lung-colonv enhancing )roperty of CY. They gave the drug 2 days before the C22LR osteosarcoma cells and observed an enhancement factor of 158-1000. As shown in Fig. 1 , we have found that the enhancement, of Lewis lung-cell cloning is broadly time-dependent, although a useful gain was observed for intervals from 6 h to 6 days before the cells. During the preparation of this report, Carmel and Brown (1977) have published a description of their experiments on the enhancement by CY of luing cloning by the KHT sarcoma. These investigators also found considerable enhancement of lung-colony formation, whose time-relation was broadly consistent with what we have found. Thev examined the influence of anticoagulants on ltung-colony formation, and concluded from these experiments, and from the effect of CY combined with whole-bodv irradiationi, that neither specific immunological nor clotting factors were involved in the CY effect.
Our resuLlts with local thoracic irradiation compare well with the work of Brown (1973) who found that 2000 rad to the thorax increased the lung-cloning efficiency of the KHIT sarcoma by a factor of 6. The time-course of his enhancement seemed similar to that observed here with whole-body irradiation (Fig. 1) but more work would be required to consolidate this finding. Withers and Milas (1973) found that the lung-cloning efficiency of a chemically induced C3H mouse fibrosarcoma was increased by a factor of 10 after 1000 rad thoracic irradiation, this maximum value occurring 1 day after irradiation. Bearing in mind that van Putten et al. (1975) (Malmgren, 1968; Hoover and Ketcham, 1975 Brown (1973) found that radiationinduced enhancement of lung cloning was associated with a reduced clearance rate of 1251-labelled cells from the lungs during the first 2 days after implantation. Essentially all the labelled cells were trapped in the lungs within 5 min, but within 12 h the irradiated lungs retained significantly more radioactivity. This does not necessarily indicate that pre-irradiation delays the escape of viable cells from the lung: the results may reflect a higher survival of viable cells within the irradiated lungs. In this respect our results on i.m. implantation (Fig. 4) are interesting. Peters and Hewitt (1974) have suggested that the effect of lethally irradiated cells in reducing the number of viable cells required to form a tumour graft is the result of their stimulation of a local clotting mechanism. We have found that treatment with CY almost abolishes the need for lethally irradiated cells, and although we cannot rule out the possibility that this treatment also enhances cell retention at the injection site, we would favour the hypothesis that CY acts by depressing the nonspecific cellular defence mechanisms, either in the lung or intramuscularly.
